–Third synthetic royalty transaction & second pre-approval deal for DRI – – Further increases portfolio exposure…
Continue ReadingTag: Thyroid
Thyroid Eye Disease Treatments Industry Analysis, 2025-2032
Dublin, Dec. 17, 2025 (GLOBE NEWSWIRE) — The “Thyroid Eye Disease Treatments Market – Global Forecast…
Continue ReadingShanghai Baiyi Healthcare Technology Showcases Innovative Medical Technology at International Forum, Driving Standardization in the Diagnosis and Treatment of Thyroid Eye Disease
London, United Kingdom–(Newsfile Corp. – September 29, 2025) – The 2025 Global Forum of the European…
Continue Reading
Leading the way in Thyroid Eye Disease
Leading the way in Thyroid Eye Disease Miss Vickie Lee…
Continue Reading
Sling Therapeutics to Announce Topline Results from Phase 2b/3 LIDS Clinical Trial of Oral Small Molecule Linsitinib in Patients with Thyroid Eye Disease at the 43rd Annual J.P. Morgan Healthcare Conference
ANN ARBOR, Mich., Jan. 13, 2025 /PRNewswire/ — Sling Therapeutics, Inc., a late-stage biopharmaceutical company focused…
Continue Reading